Company intelligence / Profile preview

Major Biotech

Shanghai, Shanghai, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Majorbiotech (Majorbio) is a leading Chinese contract research organization (CRO) specializing in high-throughput sequencing and multi-omics services. The company provides a comprehensive suite of solutions including genomics, transcriptomics, proteomics, and metabolomics to support academic research, clinical diagnostics, and pharmaceutical development. Majorbio is particularly well-known for its proprietary 'Majorbio Cloud' platform, which offers researchers automated bioinformatics analysis and data visualization tools. Headquartered in Shanghai, the company serves a global clientele across the life sciences and healthcare sectors.

Industry: Contract Research Organization

Partnerships

IlluminaThermo Fisher ScientificPacific Biosciences

Beyond the preview

Go deeper on Major Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Biotech.

Explore the full profile